Pinter, A.; Schwarz, P.; Gerdes, S.; Simon, J.C.; Saalbach, A.; Rush, J.; Melzer, N.; Kramps, T.; Häberle, B.; Reinhardt, M.
Biologic Treatment in Combination with Lifestyle Intervention in Moderate to Severe Plaque Psoriasis and Concomitant Metabolic Syndrome: Rationale and Methodology of the METABOLyx Randomized Controlled Clinical Trial. Nutrients 2021, 13, 3015.
https://doi.org/10.3390/nu13093015
AMA Style
Pinter A, Schwarz P, Gerdes S, Simon JC, Saalbach A, Rush J, Melzer N, Kramps T, Häberle B, Reinhardt M.
Biologic Treatment in Combination with Lifestyle Intervention in Moderate to Severe Plaque Psoriasis and Concomitant Metabolic Syndrome: Rationale and Methodology of the METABOLyx Randomized Controlled Clinical Trial. Nutrients. 2021; 13(9):3015.
https://doi.org/10.3390/nu13093015
Chicago/Turabian Style
Pinter, Andreas, Peter Schwarz, Sascha Gerdes, Jan C. Simon, Anja Saalbach, James Rush, Nima Melzer, Thomas Kramps, Benjamin Häberle, and Maximilian Reinhardt.
2021. "Biologic Treatment in Combination with Lifestyle Intervention in Moderate to Severe Plaque Psoriasis and Concomitant Metabolic Syndrome: Rationale and Methodology of the METABOLyx Randomized Controlled Clinical Trial" Nutrients 13, no. 9: 3015.
https://doi.org/10.3390/nu13093015
APA Style
Pinter, A., Schwarz, P., Gerdes, S., Simon, J. C., Saalbach, A., Rush, J., Melzer, N., Kramps, T., Häberle, B., & Reinhardt, M.
(2021). Biologic Treatment in Combination with Lifestyle Intervention in Moderate to Severe Plaque Psoriasis and Concomitant Metabolic Syndrome: Rationale and Methodology of the METABOLyx Randomized Controlled Clinical Trial. Nutrients, 13(9), 3015.
https://doi.org/10.3390/nu13093015
